Sildenafil Teva
From £3.99
Research Evidence for Erectile Dysfunction Treatment
Landmark Clinical Trials and Research Foundation
The clinical development of sildenafil began with extensive research programmes that established its effectiveness for erectile dysfunction. Initial pivotal trials involved over 4,000 men across multiple countries, demonstrating significant improvements in erectile function compared to placebo. These foundational studies established the evidence base that led to regulatory approval in the UK and worldwide. The research showed that sildenafil could help men achieve and maintain erections suitable for sexual activity when sexually aroused.
Efficacy Data and Success Rates
Clinical studies consistently demonstrate that sildenafil may be effective for approximately 70-80% of men with erectile dysfunction across various underlying causes. Research indicates that the medication works by selectively inhibiting the PDE5 enzyme, which increases blood flow to the penis during sexual arousal. Studies show that effectiveness can vary based on individual factors including age, underlying health conditions, and severity of erectile dysfunction. The evidence suggests that many men experience improvements in their ability to achieve and maintain erections within 30-60 minutes of taking the medication.
Safety Profile and Adverse Events
Extensive clinical research has established a well-characterised safety profile for sildenafil. Common side effects reported in studies include headache, facial flushing, indigestion, and nasal congestion, which are generally mild to moderate and temporary. Serious adverse events are rare when the medication is used appropriately under medical supervision. Clinical trials have identified important contraindications, particularly with nitrate medications, which must be avoided due to potentially dangerous blood pressure drops. Long-term safety data from post-marketing surveillance continues to support the favourable risk-benefit profile when prescribed appropriately.
Comparative Research: Branded vs Generic Options
Bioequivalence studies demonstrate that generic sildenafil contains the same active ingredient as branded Viagra and produces equivalent therapeutic effects. Regulatory authorities require generic medications to meet strict standards proving they work in the same way as the original branded product. This means patients can choose between branded Viagra or generic sildenafil based on personal preference and cost considerations, with confidence in equivalent clinical outcomes. At EverydayMeds, both options are available following consultation with qualified prescribers.
Ongoing Research and Evidence Updates
Clinical research continues to expand understanding of sildenafil's role in treating erectile dysfunction. Recent studies examine optimal dosing strategies, combination approaches, and effectiveness in specific patient populations. Real-world evidence studies complement clinical trial data by examining treatment outcomes in routine clinical practice. This ongoing research helps healthcare providers make evidence-based prescribing decisions and ensures treatment recommendations remain current with the latest scientific evidence.
